Adeberg
            
            @adeberg.bsky.social
          
          57 followers
          170 following
          18 posts
        
          ☢️⚡️Radiation oncologist, medical scientist and athlete – passionate about innovations and transformation in healthcare. I share insights into cancer research, health strategies, and the future of personalized medicine. 🎯
mit-marburg.de/
      
        Posts
        Media
        Videos
        Starter Packs
      
    
        
      Pinned
    
  
          
              Adeberg
              @adeberg.bsky.social
          
              · 12d
        
        
          
      🎥 50 years of key moments.
ESMO’s 50th anniversary marks decades of achievements in #ScienceDissemination, #education and #collaboration. Take a selfie and share one of your milestones with #myESMOStory. #ESMO25
🔗 www.youtube.com/watch?v=dJTH...
        ESMO’s 50th anniversary marks decades of achievements in #ScienceDissemination, #education and #collaboration. Take a selfie and share one of your milestones with #myESMOStory. #ESMO25
🔗 www.youtube.com/watch?v=dJTH...
        
      Reposted by Adeberg
    
  
  
          
              Adeberg
              @adeberg.bsky.social
          
              · 12d
        
        
      
    
          
              Adeberg
              @adeberg.bsky.social
          
              · 12d
        
        
      
    
        
      Reposted by Adeberg
    
  
  
        
      Reposted by Adeberg
    
  
          
              Shicheng Guo
              @shihcheng.bsky.social
          
              · Apr 9
        
        
        
            Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity | Nature
            Metastasis is the spread of cancer cells from primary tumours to distant organs and is the cause of 90% of cancer deaths globally1,2. Metastasizing cancer cells are uniquely vulnerable to immune attack, as they are initially deprived of the immunosuppressive microenvironment found within established tumours3. There is interest in therapeutically exploiting this immune vulnerability to prevent recurrence in patients with early cancer at risk of metastasis. Here we show that inhibitors of cyclooxygenase 1 (COX-1), including aspirin, enhance immunity to cancer metastasis by releasing T cells from suppression by platelet-derived thromboxane A2 (TXA2). TXA2 acts on T cells to trigger an immunosuppressive pathway that is dependent on the guanine exchange factor ARHGEF1, suppressing T cell receptor-driven kinase signalling, proliferation and effector functions. T cell-specific conditional deletion of Arhgef1 in mice increases T cell activation at the metastatic site, provoking immune-mediated
          
            
            doi.org
          
        
      
    
        
      Reposted by Adeberg
    
  
          
              Dr. Jens Foell
              @jensfoell.de
          
              · Mar 28
        
        
          
      THREAD
The numbers are in. @bsky.app research sharing volumes vs X Formerly Twitter
In March 2024, on most days, Bluesky hosts more posts linked to research published in 2025 than X.
By quite a lot.
Release the Kraken...
#AcademicSky #HigherEd #Altmetrics
1/11
        The numbers are in. @bsky.app research sharing volumes vs X Formerly Twitter
In March 2024, on most days, Bluesky hosts more posts linked to research published in 2025 than X.
By quite a lot.
Release the Kraken...
#AcademicSky #HigherEd #Altmetrics
1/11
          
              Adeberg
              @adeberg.bsky.social
          
              · Mar 27
        
        
      
    
          
              Adeberg
              @adeberg.bsky.social
          
              · Mar 27
        
        
      
     
        